Home > Drug Search >
  • company_query: Altair Therapeutics
  •   > 
Drug Filter
Category:
chemistry (18) biology (1)
Status:
Approved (1) Phase Ⅲ (6) Phase Ⅱ (8) Phase Ⅰ (4)
Clinical Stage:
Pending (4) Active (8) Discontinued (6)
Indication:
Alzheimer's disease (AD) (1) Anaesthetic (1) Breast cancer (1) Chronic neuropathic pain (1) Cognitive disorders (1) Diabetic nephropathy (1) Inflammatory bowel disease (1) Insomnia (1) Lymphoma (1) Myocardial infarction (MI) (1) Neuropathic pain (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Peptic ulcer (1) Poliomyelitis (1) Psoriasis (1) Schizophrenia (1) Solid tumours (1) Otitis Media (1) Rett's syndrome (1) Allergic asthma (1) Celiac disease (1) Arterial occlusive disease (1) Coronary restenosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top